All filters
E-Posters
Reducing Read Time Of Point Of Care Test Preserves Detection Of Hepatitis C Virus And Reduces Need For Reflex RNA
D. Smookler
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Frequency Of Occult Hepatitis B Virus Among Blood Donors In Khartoum State, Sudan: A Preliminary Study
M. Yassin
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
A Novel Point -Of- Care Test (POC) For Diagnosis Of Hepatitis Core Antigen
G. Shiha
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Detection Of Viral Hepatitis And Linking To The Health Care Of Trans People - Incide Project Contributions
F. Frazão de Aguiar
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
High Seroprevalence Of Viral Hepatitis Among Animal Handlers In Abeokuta, Nigeria
A. Oluremi
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Validation Of A Novel Point-Of-Care Alt Test To Determine Treatment Eligibility In Hepatitis B Patients: A Pilot Cohort Study
J. Howell
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Seroprevalence Of Hepatitis B Surface Antigen (HBsAg) And Hepatitis C Antibodies (HCAb) Among Hemodialysis Patients At The Yaounde General Hospital, Cameroon
K. W. Rodrigue
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Expression Of HBeAg, HBsAg, Anti- HBe And Anti-HCV In Individuals With Elevated Il-10
M. F. Olaniyan
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Seroprevalence Of Viral Hepatitis Among Health Care Workers (HCWs) In Taraba State, Nigeria
O. Tiwah John
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Results From Two Phase-3 Double-Blind, Randomized, Controlled Trials, Protect And Constant, Evaluating Immunogenicity And Safety Of The 3-Antigen Hepatitis B Vaccine, Sci-B-Vac®, Compared To The Single-Antigen Vaccine, Engerix ® In Adults
F. Diaz-Mitoma
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Evaluation Of Hepatitis B Vaccine Efficacy Among Healthcare Worker At Laquintinie Hospital, Douala, Cameroon
K. W. Rodrigue
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Hep Free 2030: Planning For Hepatitis Elimination In Hawaii As Nimble, Collaborative Practice
T. Pham
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Ledipasvir 90 Mg/ Sofosbuvir 400 Mg For Treatment Of Chronic Hepatitis C Genotype 4 Adolescents: Towards Elimination Of Hepatitis In Children
R. Soliman
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Results Of A Hepatitis C (HCV) Re-Engagement Strategy For Vulnerable Populations
G. Macphail
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Gilead Sciences’ Commitment To Global Elimination Of Hepatitis C Virus
A. Son
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Contact Tracing To Engage Hard To Reach Injection Networks And Achieve Micro-Elimination: Description Of The ‘Source Patient Indentification And Group Overlap Treatment’ (Spigot) Pilot Program
B. Eckhardt
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Global Elimination Of Hepatitis C: Meeting The World Health Organization’S 2030 Goal
E. Abernathy
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020